Albert Labs International Corp. (CSE:ABRT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Jul 15, 2024, 8:38 AM EST
Market Cap372.07K
Revenue (ttm)n/a
Net Income-2.31M
EPS-0.04
Shares Out74.41M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume23,765
Openn/a
Previous Close0.0050
Day's Range0.0050 - 0.0050
52-Week Range0.0050 - 0.0400
Beta2.42
RSI39.74
Earnings DateNov 28, 2025

About Albert Labs International

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Navchand Jagpal
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol ABRT
Full Company Profile

Financial Performance

Financial Statements